Phase II study of 5-fluorouracil leucovorin and azidothymidine in patients with metastatic colorectal cancer

Journal of Cancer Research and Clinical Oncology

Volumn 122, Issue 9, 1996, Pages 554-558

  Clark, Jeffrey ^a,c   Sikov, William ^a   Cummings, Frank ^a   Browne, Marcia ^a   Akerley, Wallace ^a   Wanebo, Harrold ^a   Weitberg, Alan ^a   Kennedy, Teresa ^a   Cole, Bernard ^a   Bigley, Joseph ^b   Beitz, Julie ^a   Darnowski, James ^a  

^a BROWN UNIVERSITY   (United States)

^b Burroughs Wellcome   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

AZT; Colon cancer; Fluorouracil; Leucovorin

Indexed keywords

FLUOROURACIL; FOLINIC ACID; ZIDOVUDINE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; LUNG METASTASIS; MALE; ORAL DRUG ADMINISTRATION; PERITONEUM METASTASIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 9444289362     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01213552     Document Type: Article

References (37)

1. Advanced Colorectal Cancer Meta-analysis Project (1992) Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 10:896-903
2. Advanced Colorectal Cancer Meta-analysis Project (1994) Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. J Clin Oncol 12:960-969
3. Ahmed NK (1984) Enzymes of the de novo and salvage pathways for pyrimidine biosynthesis in normal colon, colon carcinoma, and xenografts. Cancer 54:1370-1373
4. Arbuck SG (1989) Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer. Cancer 63:1036-1044
5. Beitz JG, Darnowski JW, Cummings FJ, Brownc MJ, Clark JW, Bigley JW, Wcitberg AB (1995) Phase I trial of high dose infused zidovudine combined with leucovorin plus fluorouracil. Cancer Invest 13:464-469
6. Broder S, Mitsuya H, Yarchoan R, Pavlakis GN (1990) NIH Conference. Antiretroviral therapy in AIDS. Ann Intern Med 113: 604-618
7. Brunetti I, Falcone A, Calabresi P, Goulette KA, Darnowski JW (1990) 5-Fluorouracil enhances azidothymidine cytoloxicity: in vitro, in vivo and biochemical studies. Cancer Res 50:4028-2031
8. Cohen AM, Minsky BD, Schilsky RL (1993) Colon cancer. In: DeVita VT Jr. Hellman S, Rosenberg SA (eds) Cancer principles and practice of oncology. Lippincott, Philadelphia, pp 929-977
9. Copeland WC, Chen MS, Wang TS (1992) Human DNA polymerases alpha and beta are able to incorporate anti-HIV deoxynucleotides into DNA. J Biol Chem 267:21459-21464
10. Darnowski JW, Goulette FA (1992) Fluorouracil increases azidothymidine cytotoxicity by altering dTTP pools. Proc Am Assoc Cancer Res 33:2511
11. Darnowski JW Goulette FA (1994) Synergistic cytoloxicity with α-Interferon and azidothymidine in HCT-8 cells reflects increased azidothymidine incorporation in DNA (abstract). Proc Am Assoc Cancer Res 35:1990
12. Darnowski JW, Renaud CA, Chu M, Goulette F, Tosi P, Calabresi P (1991) Resistance to azidothymidine cytotoxicity in the human colon tumor cell line HCT15 is associated with enhanced removal of AZT from cellular DNA (abstract). Proc Am Assoc Cancer Res 32:2124
13. Darnowski JW, Hankinson G, Goulette FA (1995) Alpha-interferon induced inhibition of DNA repair increases the cytotoxicity of azidothymidine in HCT-8 cells (abstract). Proc Am Assoc Cancer Res 36:1773
14. Dupuy J, Price M, Lynch G, Brucc S, Schwurtz M (1993) Intralesional interferon-α and zidovudine in epidemic Kaposis sarcoma. J Am Acad Dermatol 28:966-972
15. Elias L and Crissman HA (1988) Interferon effects upon the adeno-carcinoma 38 and HL-60 cell lines. Antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites. Cancer Res 48:4868-4873
16. Gill PS, Harrington, Jr W, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA, Bernstein-Singer M, Espina BM, Cabral L, Allen S, Kornblau S, Pike MC, Levine AM (1995) Treatment of adult T-cell leukemia-lymphoma with a combination of Interferon alfa and zidovudine. N Engl J Med 332:1744-1748
17. Grem JL (1995) Future challenges for the systemic therapy of metastatic colorectal cancer. ASCO Educational Book. American Society of Clinical Oncology. Chicago, pp 55-58
18. Hermine O, Bouscary D, Gessain A, Turlure P, Lebland V, Franck N, Buzyn-Veil A, Rio B, Macintyre E, Dreyfus E, Bazarbachi A (1995) Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and Interferon alfa. N Engl J Med 332:1749-1750
19. Hill M, Norman A, Cunningham D, Findlay M, Nicolson V, Hill A, Iveson A, Evans C, Joffe J, Nicolson M, Hickish T (1995) Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer. J Clin Oncol 13: 1297-1302
20. Kemeny N, Lokich JJ, Andersen N, Ahlgren JD (1993) Recentn advances in the treatment of advanced colorectal cancer. Cancer 71:9-18
21. Krown SE. Gold JWM, Niedzwiecki D, Bundow D, Flomenberg N, Gansbacher B, Brew BJ (1990) Interferon-α with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS). Ann Int Med 112:812-821
22. Krown SE, Paredes J, Bundow D, Polsky B, Gold JWM, Flomenberg N (1992) Interferon-α, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS clinical trials group study in patients with Kaposi's sarcoma associated with AIDS. J Clin Oncol 10:1344-1351
23. Moran RG (1989) Leucovorin enhancement of the effects of fluoropynmidines on thymidylate synthase. Cancer 63:1008-1012
24. Paterson ARP, Kolassa N,. Cass CE (1981) Transport of nucleoside drugs in animal cells. Pharmacol Ther 12:516-536
25. Podzamczer D, Bolao F, Clotet B, Garcia P, Casanova A, Pagerols X, Gudiol F (1993) Low-dose interferon alpha combined with zidovudine in patients with AIDS associated Kaposi's sarcoma. J Intern Med 233:247-253
26. Poon MA, O'Connell MJ, Moertel CG, Wieand HS, Cullnan SA, Everson LK, Krook JE, Mailliard JA, Laurie JA, Tschetter LK, Wiesenfeld M (1989) Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 7:1407-1418
27. Posner MR, Darnowski JW, Calabresi P, Brunetti I, Corvese D, Curt G, Clark JW, Browne MJ, Beitz J, Weitberg AB (1990) Oral azidothymidine. continuous infusion 5-fluorouracil and oral leucovorin: a phase 1 study. J Natl Cancer Inst 82:1710-1714
28. Posner MR, Darnowski JW, Weitberg AB, Dudley MN, Corvese D, Cummings FJ, Clark J, Murray C, Clendennin N, Bigley J, Calabresi P (1992) High-dose intravenous zidovudine With 5-fluorouracil and leucovorin. Cancer 70:2929-2934
29. Preiss J (1992) Fluorouracil plus interferon + folinic acid in regional and systemic therapy in colorectal cancer. Semin Oncol 19 [Suppl 3]:220-224
30. Pressacco J, Erlichman C (1993) Combination studies with 3′-azido-3′-deoxythymidine (AZT) plus ICI D1694. Cytotoxic and biochemical effects. Biochem Pharmacol 46:1989-1997
31. Raderer M, Scheithauer W (1995) Treatment of advanced colorectal cancer with 5-fluorouracil and interferon-α: an overview of clinical trials. Eur J Cancer 31A: 1002-1008
32. Slichenmyer WJ, Rowinsky EK, Donehower RC, Kaufmann SH (1993) The current status of camptothecin analogues as antitumor agents. J Nail Cancer Inst 85:271 -291
33. Tosi P, Visani G, Ottaviani E, Gamberi B, Cenacehi A, Tura S (1993) Synergistic cytotoxicity of AZT plus alpha and gamma Interferon in chronic myeloid leukemia cell line K562. Eur J Haematol 51:209 -213
34. Wadler S, Wersto R, Weinberg V, Thompson D, Scwartz EL (1990) Interaction of Fluorouracil and Interferon in human colon cancer cell lines. Cytotoxic and cytokinetic effects. Cancer Res 50:5735 -5739
35. Weber G, Ichikawa S, Nagai M, Natsumeda Y (1990) Azido-thymidine inhibition of thymidine kinase and synergistic cytotoxicity with methotrexate and 5-fluorouracil in rat hepaloma and human colon cancer cells. Cancer Commun 2:129 -133
36. Wilde MI, Lantry HD (1993) Zidovudine. An update of its pliarmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 46:515 -578
37. Zhen YS, Taniki T, Weber G (1992) Azidothymidine and dipyrimidole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells. Oncol Res 4:73 -78